In summary, our study supported evidence that genetically determined IL-4 levels are related to the reduced risk of ischemic stroke, suggesting that regulation and intervention of certain inflammatory factors might represent an effective strategy for the future treatment and prevention of ischemic stroke. The gene discussed is IL4; the disease is ischemic stroke.